Cadherin-11 expression, an assay and treatment for cellular invasiveness
CA 2349835 A1 · Owner: Maccalman, Colin D. · Inventors: Maccalman, Colin D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of modulating differentiation or neoplastic transformation of cells is provided in which the cells are caused to increase or decrease cad-11 expression or function. Such method has application in affecting differentiation or neoplastic transformation of cells preventing or , terminating pregnancy by altering cad-11 function or expression in trophoblast cells, or for reducing the viability of carcinoma cells having a low to moderate metastatic potential. The use of agents which increase or decrease cad-11 expression or function is also provided including such use for , preparation of medicaments for modulating differentiation or neoplastic transformation of cells. A method …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 29, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 29, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 29, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.